SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-21-000157
Filing Date
2021-05-18
Accepted
2021-05-17 18:18:58
Documents
11
Period of Report
2021-05-17

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF MAY 2021 imv6kmpm.htm 6-K 5648
2 LETTER TO SHAREHOLDERS exhibit99-1.htm EX-99.1 2529
3 AMENDED MANAGEMENT INFORMATION CIRCULAR exhibit99-2.htm EX-99.2 354806
4 AMENDED FORM OF PROXY exhibit99-3.htm EX-99.3 936
5 exhibit99-1x1x1.jpg GRAPHIC 13193
6 exhibit99-2x1x1.jpg GRAPHIC 8375
7 exhibit99-2x6x1.jpg GRAPHIC 39343
8 exhibit99-2x27x1.jpg GRAPHIC 54848
9 exhibit99-2x49x1.jpg GRAPHIC 9388
10 exhibit99-3x1x1.jpg GRAPHIC 528625
11 exhibit99-3x2x1.jpg GRAPHIC 440204
  Complete submission text file 0001176256-21-000157.txt   1872595
Mailing Address 130 EILEEN STUBBS AVE. SUITE 19 DARTMOUTH A5 B3B 2C4
Business Address 130 EILEEN STUBBS AVE. SUITE 19 DARTMOUTH A5 B3B 2C4 9024921819
IMV Inc. (Filer) CIK: 0001734768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38480 | Film No.: 21933022
SIC: 2834 Pharmaceutical Preparations